Legacy Wealth Management (Mississippi)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Legacy Wealth Management (Mississippi)'s ABBV Position: Q2 2026 in Review
Legacy Wealth Management (Mississippi) increased its AbbVie (ABBV) stake by 8.6% in Q2 2026, buying an estimated $17.2K and bringing the position to 1,014 shares worth $255K. The position accounts for 0.07% of the portfolio, ranked #107.
Legacy Wealth Management (Mississippi) first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $321K in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Legacy Wealth Management (Mississippi) held 1,014 shares of AbbVie worth $255K as of Q2 2026.
- Legacy Wealth Management (Mississippi) bought 80 AbbVie shares in Q2 2026, an estimated $17.2K.
- AbbVie made up 0.07% of Legacy Wealth Management (Mississippi)'s portfolio in Q2 2026, its #107 holding.
- Legacy Wealth Management (Mississippi) first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
- Legacy Wealth Management (Mississippi)'s AbbVie position peaked at $321K in Q3 2024.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Legacy Wealth Management (Mississippi)'s 13F filing for Q2 2026, filed 8 Jul 2026.